Dr. Michael Chen
CHIEF SCIENTIFIC OFFICER
TBG Diagnostics
Australia
Biography
Michael received his Ph.D degree in Molecular Biology from the University of North Texas and his Postdoctoral fellowship training in Molecular and Cellular Genetics Biology from the Johns Hopkins Hospital School of Medicine. Before Michael founded Texas BioGene, Inc. (TBG) in 1999, he held positions as a Director of Research and Development at BioSynthesis, Inc. and an adjuvant professor at the Biology Department at UNT. He has further received research grant awards for studies of glaucoma gene expressions, structural biology of bacterial toxins, and peptide mediated gene transfer from government departments such as the National Institute of Health (NIH) or industrial companies like Alcon Corp.. Michael has focused and specialized on molecular diagnostic methodology and enzyme/protein engineering since he joined TBG Biotechnology Corp. as a Chief Scientist Officer since 2006.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
